Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

Eli Lilly is a leader in the market for GLP-1 medicines. The company's Zepbound, indicated for weight loss, is racking up billions in quarterly sales. Its only real competitor in weight management is ...